Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Fecal Microbiota Transplantation (FMT) + Pembrolizumab & Non-small-cell lung cancer (NSCLC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Non-randomized clinical trials

NCT04951583
The findings confirm that FMT, when used in combination with ICI, shows clinical activity. They also suggest that for FMT to provide therapeutic benefits, it is necessary to eliminate harmful taxa (1)

References

(1) Duttagupta et al. 2026 Nat Med 32: 1337-1350

…

References (Sources)

Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial
Duttagupta et al. 2026 Nat Med 32: 1337-1350

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!